🔗 Share this article TikTok Influencers Driving Unofficial Market for Unapproved Slimming Medication An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations. Experimental Drug Acquiring Traction Online The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers. Active Commerce on Messaging Platforms Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to other platforms for transactions. Learning About Retatrutide Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic. Medical Experts Express Worries However, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin. Several professionals said the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro. Regulatory Position and Implementation Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations. Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison. Platform Reaction and Material Elimination Based on the social media company, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in strengthening compliance measures. Online Marketplace Operations Research also found communities with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and detailed guides for preparing or injecting at residence. After minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or past usage. Item Information and Costs Within these groups, messages display black plastic parcels with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.” Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”. Platform Oversight and Security Measures A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “People are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U. A medical professional of an online medical service connected the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained. Her staff has already encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.” Producer Position A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious medical dangers”.